Mendelian Randomization Results Showing the Causal Associations of eBMD With 2hGlu and T2DM
Exposure | Outcome | Methods | SNPs | Estimatea | 95% CI | p | Q‐statistic | Q p | p for MR‐Egger intercept test |
eBMD | 2hGlu | IVW | 539 | 0.043 | 0.007, 0.079 | 0.020 | 428.401 | >0.999 | |
Weighted median | 0.015 | −0.044, 0.073 | 0.627 | ||||||
ConMix | 0.060 | 0.020, 0.100 | 0.015 | ||||||
MR‐Egger | −0.007 | −0.074, 0.060 | 0.834 | 0.083 | |||||
T2DM | IVW | 479 | 1.064 | 1.036, 1.093 | <0.001 | 451.349 | 0.804 | ||
Weighted median | 1.085 | 1.039, 1.134 | <0.001 | ||||||
ConMix | 1.062 | 1.020, 1.128 | 0.010 | ||||||
MR‐Egger | 1.063 | 1.012, 1.116 | 0.015 | 0.946 |
Exposure | Outcome | Methods | SNPs | Estimatea | 95% CI | p | Q‐statistic | Q p | p for MR‐Egger intercept test |
eBMD | 2hGlu | IVW | 539 | 0.043 | 0.007, 0.079 | 0.020 | 428.401 | >0.999 | |
Weighted median | 0.015 | −0.044, 0.073 | 0.627 | ||||||
ConMix | 0.060 | 0.020, 0.100 | 0.015 | ||||||
MR‐Egger | −0.007 | −0.074, 0.060 | 0.834 | 0.083 | |||||
T2DM | IVW | 479 | 1.064 | 1.036, 1.093 | <0.001 | 451.349 | 0.804 | ||
Weighted median | 1.085 | 1.039, 1.134 | <0.001 | ||||||
ConMix | 1.062 | 1.020, 1.128 | 0.010 | ||||||
MR‐Egger | 1.063 | 1.012, 1.116 | 0.015 | 0.946 |
2hGlu = 2‐h glucose level after an oral glucose challenge test; ConMix = Contamination Mixture; eBMD = estimated bone mineral density; BMI = body mass index; IVW = inverse‐variance weighted; MR = Mendelian randomization; CI = confidence interval; OR = odds ratio; SD = standard deviation; SNP = single‐nucleotide polymorphism; T2DM = type 2 diabetes mellitus.
Estimates are presented as standardized β for 2hGlu and OR for T2DM per SD increase in eBMD.
Mendelian Randomization Results Showing the Causal Associations of eBMD With 2hGlu and T2DM
Exposure | Outcome | Methods | SNPs | Estimatea | 95% CI | p | Q‐statistic | Q p | p for MR‐Egger intercept test |
eBMD | 2hGlu | IVW | 539 | 0.043 | 0.007, 0.079 | 0.020 | 428.401 | >0.999 | |
Weighted median | 0.015 | −0.044, 0.073 | 0.627 | ||||||
ConMix | 0.060 | 0.020, 0.100 | 0.015 | ||||||
MR‐Egger | −0.007 | −0.074, 0.060 | 0.834 | 0.083 | |||||
T2DM | IVW | 479 | 1.064 | 1.036, 1.093 | <0.001 | 451.349 | 0.804 | ||
Weighted median | 1.085 | 1.039, 1.134 | <0.001 | ||||||
ConMix | 1.062 | 1.020, 1.128 | 0.010 | ||||||
MR‐Egger | 1.063 | 1.012, 1.116 | 0.015 | 0.946 |
Exposure | Outcome | Methods | SNPs | Estimatea | 95% CI | p | Q‐statistic | Q p | p for MR‐Egger intercept test |
eBMD | 2hGlu | IVW | 539 | 0.043 | 0.007, 0.079 | 0.020 | 428.401 | >0.999 | |
Weighted median | 0.015 | −0.044, 0.073 | 0.627 | ||||||
ConMix | 0.060 | 0.020, 0.100 | 0.015 | ||||||
MR‐Egger | −0.007 | −0.074, 0.060 | 0.834 | 0.083 | |||||
T2DM | IVW | 479 | 1.064 | 1.036, 1.093 | <0.001 | 451.349 | 0.804 | ||
Weighted median | 1.085 | 1.039, 1.134 | <0.001 | ||||||
ConMix | 1.062 | 1.020, 1.128 | 0.010 | ||||||
MR‐Egger | 1.063 | 1.012, 1.116 | 0.015 | 0.946 |
2hGlu = 2‐h glucose level after an oral glucose challenge test; ConMix = Contamination Mixture; eBMD = estimated bone mineral density; BMI = body mass index; IVW = inverse‐variance weighted; MR = Mendelian randomization; CI = confidence interval; OR = odds ratio; SD = standard deviation; SNP = single‐nucleotide polymorphism; T2DM = type 2 diabetes mellitus.
Estimates are presented as standardized β for 2hGlu and OR for T2DM per SD increase in eBMD.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.